Detail of "7025-19-6"

Reference

Inhibitors of Epstein-Barr virus nuclear antigen 1, screening methods, and therapeutic use

All Rights Reserved. Inhibitors of Epstein-Barr virus nuclear antigen 1, screening methods, and therapeutic use. Kieff, Elliott; Kang, Myung-Soo (The Brigham and Women's Hospital, Inc., USA). PCT Int. Appl. WO 2007002587 A2 4 Jan 2007, 66pp. DESIGNATED STATES: W: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC; RW: AT, BE, BF, BJ, CF, CG, CH, CI, CM, CY, DE, DK, ES, FI, FR, GA, GB, GR, IE, IS, IT, LU, MC, ML, MR, NE, NL, PT, SE, SN, TD, TG, TR. (English). (World Intellectual Property Organization). CODEN: PIXXD2. APPLICATION: WO 2006-US24807 26 Jun 2006. PRIORITY: US 2005-693685P 24 Jun 2005. DOCUMENT TYPE: Patent CA Section: 1 (Pharmacology) The invention relates to a high throughput assay and methods for detecting inhibitors. The invention also relates to the inhibitors identified by the assay methods, and methods of using the inhibitors to treat and prevent Epstein-Barr virus-related diseases.Except for chemicals metioned above, 7025-19-6 and 303101-72-6 are also used. .